A clinical trial measuring a new clinical psychology intervention on improving outcomes for people with schizophrenia and distressing voice hallucinations.
Not Applicable
- Conditions
- schizophreniaMental Health - Schizophrenia
- Registration Number
- ACTRN12616001499471
- Lead Sponsor
- orth Metropolitan Health Service -Adult Mental Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Diagnosis of schizophrenia spectrum disorder defined by DSM-V; experiencing distressing voice hallucinations; has not previously received or is currently receiving CPV; voluntary or involuntary resident of SCGH Mental Health Unit Tanami ward; plans to reside in Australia for the duration of follow-ups; available for follow-up for at least 6 months; able to comply with requirements of the protocol; able and willing to understand and provide written informed consent; between 18 and 65 years of age.
Exclusion Criteria
Woman during the lactation period or pregnant; patient highly dependent on medical care; significant communication barrier.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method